Biotech Beach
Filter News
Found 77,229 articles
-
Gilead Sciences, Inc. Announces Record Fourth Quarter and Full Year 2009 Financial Results
1/27/2010
-
Somaxon Pharmaceuticals, Inc. to Present at the 12th Annual BIO CEO & Investor Conference
1/27/2010
-
Prometheus Laboratories Inc. (JOBS) Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
1/26/2010
-
The Burnham Institute (JOBS) to Get $50 Million
1/26/2010
-
Aethlon Medical Discloses Hepatitis-C (HCV) Treatment Publication
1/26/2010
-
Cytori Therapeutics, Inc. Issued U.S. Patent for Cell-Enriched Fat Grafting; New Patent Protects Key Cytori Market
1/26/2010
-
Radient Pharmaceuticals Submits Business Plan for Continued NYSE Amex Listing
1/26/2010
-
La Jolla Pharmaceutical Company Receives Nasdaq Delisting Notice and Intends to Appeal Determination
1/26/2010
-
International Stem Cell Corporation Progresses towards Establishment of the Industry's First Universal Stem Cell Bank, UniStemCell(TM)
1/26/2010
-
MannKind Corporation to Hold 2009 Fourth Quarter and Full Year Financial Results Conference Call on February 1, 2010
1/26/2010
-
University of California, San Diego (UCSD) Researchers Synchronize Blinking 'Genetic Clocks' -- Genetically Engineered Bacteria That Keep Track of Time
1/25/2010
-
Spectrum Pharmaceuticals, Inc. Says FDA Asks for More Data on Cancer Drug
1/25/2010
-
Common Heart Medications May Also Protect Against Parkinson's Disease, University of California, Los Angeles (UCLA) Study Finds
1/25/2010
-
Edwards Lifesciences Corporation Initiates Clinical Study of Minimally Invasive Aortic Valve Surgery System
1/25/2010
-
Fluidigm Corporation and IntegraGen SA Join Forces to Create a Genetic Analysis Service and European Demonstration Lab
1/25/2010
-
Cyntellect, Inc. Expands Network Across Asia with Far Reaching Distribution Partnerships
1/25/2010
-
HemaCare Corp. Announces New Blood Services Contracts
1/25/2010
-
AIDS Healthcare Foundation Bans Merck’s Drug Reps from Its Clinics
1/25/2010
-
Arrayit Corporation's Proteomic Biomarkers Clear the Way for Pre-Symptomatic Detection of Ovarian Cancer and Other Major Diseases
1/25/2010
-
Regulus Therapeutics, Inc., Alnylam Pharmaceuticals and Isis Pharmaceuticals, Inc. Announce U.S. Allowance of Tuschl III Patent Application Covering miR-21
1/25/2010